DerickHon ManLauMD

Oncology • Roseville, CA

Director of New Hope Cancer Center, Beijing, China

Join to view full profile

Dr. Lau is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lau's full profile

Already have an account?

Office
Jiang Tai Road, #2
Beijing, China
Roseville, CA 95747
Phone+1 916-698-7980
Is this information wrong?

Education & Training

University of California Davis HealthFellowship, Hematology and Medical Oncology, 1990 - 1991
Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 1987 - 1989
University of California (San Francisco)/FresnoResidency, Internal Medicine, 1984 - 1987
University of Missouri-Columbia School of MedicineClass of 1984

Certifications & Licensure

CA State Medical License 1985 - 2024
American Board of Internal Medicine Internal Medicine

Clinical Trials

S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer Start of enrollment: 1998 Feb 01
Completed
Phase 2
Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer Start of enrollment: 2002 Mar 01
Completed
Phase 1
S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2006 Jul 01
Terminated
Phase 2
S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Start of enrollment: 2006 Apr 01
Terminated
Phase 1
Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer Start of enrollment: 2001 Oct 01
Completed
Phase 2
S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma Start of enrollment: 2007 Jul 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

11 citations
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors
Marianna Koczywas, Paul Frankel, Timothy W. Synold, Heinz-Josef Lenz, Joanne E. Mortimer, Anthony B. El-Khoueiry, David R. Gandara, Mihaela C. Cristea, Vincent Chung, ...> ;British Journal of Cancer. 2014 Dec 9
6 citations
Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer
Cheryl Ho, Angela M. Davies, Randeep Sangha, Derick H Lau, Primo N. Lara, Helen K. Chew, Laurel A. Beckett, Philip C. Mack, Jonathan W. Riess, David R. Gandara> ;Investigational New Drugs. 2013 Sep 8
54 citations
Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
Allen M. Chen, Megan E. Daly, D. Gregory Farwell, Esther Vazquez, Jean Courquin, Derick H Lau, James A. Purdy> ;JAMA Otolaryngology-- Head & Neck Surgery. 2014 Feb 1
10 citations
A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer
Yuhchyau Chen, James J. Moon, Kishan J. Pandya, Derick H Lau, Karen Kelly, Fred R. Hirsch, Laurie E. Gaspar, Mary W. Redman, David R. Gandara> ;Frontiers in Oncology. 2013 Aug 28
41 citations
Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer
Megan E. Daly, Derick H Lau, D. Gregory Farwell, Quang Luu, Paul J. Donald, Allen M. Chen> ;American Journal of Otolaryngology. 2013 Nov 1
6 citations
Southwestern oncology group phase II trial (S0526) of pemetrexed in bronchioloalveolar carcinoma subtypes of advanced adenocarcinoma.
Derick H Lau, James J. Moon, Angela M. Davies, Rachel E. Sanborn, Fred R. Hirsch, Wilbur A. Franklin, Janet C. Ruzich, Mary W. Redman, David R. Gandara> ;Clinical Lung Cancer. 2013 Jul 1
38 citations
Differential response rates to irradiation among patients with human papillomavirus positive and negative oropharyngeal cancer.
Allen M. Chen, Judy Li, Laurel A. Beckett, Talia Zhara, D. Gregory Farwell, Derick H Lau, Regina F Gandour-Edwards, Andrew T M Vaughan, James A. Purdy> ;The Laryngoscope. 2013 Jan 1
45 citations
Brachial Plexus-Associated Neuropathy After High-Dose Radiation Therapy for Head-and-Neck Cancer
Allen M. Chen, William H. Hall, Judy Li, Laurel A. Beckett, D. Gregory Farwell, Derick H Lau, James A. Purdy> ;International Journal of Radiation Oncology, Biology, Physics. 2012 Sep 1
45 citations
Intensity-Modulated Radiotherapy is Associated With Improved Global Quality of Life Among Long-term Survivors of Head-and-Neck Cancer
Allen M. Chen, D. Gregory Farwell, Quang Luu, Esther Vazquez, Derick H Lau, James A. Purdy> ;International Journal of Radiation Oncology, Biology, Physics. 2012 Sep 1
25 citations
Intercalated Erlotinib-Docetaxel Dosing Schedules Designed to Achieve Pharmacodynamic Separation: Results of a Phase I/II Trial
Randeep Sangha, Angela M. Davies, Primo N. Lara, Philip C. Mack, Laurel A. Beckett, Paul J. Hesketh, Derick H Lau, Tianhong Li, Natasha Perkins, David R. Gandara> ;Journal of Thoracic Oncology. 2011 Dec 1
30 citations
A phase I and pharmacokinetic study of oral 3-aminopyridine-2- carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: A...
Joseph Chao, Timothy W. Synold, Robert J. Morgan, Charles A. Kunos, Jeff Longmate, Heinz-Josef Lenz, Dean Lim, Stephen Shibata, Vincent Chung, Ronald G. Stoller, Chand...> ;Cancer Chemotherapy and Pharmacology. 2012 Mar 1
3 citations
Feasibility study of intra-patient sorafenib dose-escalation or re-escalation in patients with previously treated advanced solid tumors.
Thomas J. Semrad, Courtney Eddings, Chong-Xian Pan, Derick H Lau, David R. Gandara, Laurel A. Beckett, Primo N. Lara> ;Investigational New Drugs. 2012 Oct 1
5 citations
Voice quality after organ‐preservation therapy with definitive radiotherapy for laryngeal cancer
Valerie H. Lau, Rebecca J. Leonard, Susan Goodrich, Quang Luu, D. Gregory Farwell, Derick H Lau, James A. Purdy, Allen M. Chen> ;Head & Neck. 2012 Jul 1
Phase I study of temsirolimus (Tem) and pazopanib (Paz) in solid tumors with emphasis on renal cell carcinoma (RCC).
Semrad TJ, Eddings C, Dutia MP, Christensen S, Lau D, Lara P> ;J. Clin. Oncol.. 2011-05-20
Pilot study (SWOG S0429) of weekly cetuximab and chest radiotherapy (RT) for poor-risk stage III non-small cell lung cancer (NSCLC).
Chen Y, Moon J, Pandya KJ, Kelly K, Gaspar LE, Lau D, Hirsch FR, Gandara DR> ;J. Clin. Oncol.. 2011-05-20
148 citations
Tobacco Smoking During Radiation Therapy for Head-and-Neck Cancer Is Associated With Unfavorable Outcome
Allen M. Chen, Leon M. Chen, Andrew T M Vaughan, R. Sreeraman, D. Gregory Farwell, Quang Luu, Derick H Lau, Kerri Stuart, James A. Purdy, Srinivasan Vijayakumar> ;International Journal of Radiation Oncology, Biology, Physics. 2011 Feb 1
17 citations
Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: A california cancer consortium trial
Primo N. Lara, Jeff Longmate, Karen L. Reckamp, Barbara J. Gitlitz, Athanassios Argiris, Suresh S. Ramalingam, Chandra P. Belani, P. C. Mack, Derick H Lau, Mariana Koc...> ;Clinical Lung Cancer. 2011 Jan 1
10 citations
Primary Radiation Therapy for Head-and-Neck Cancer in the Setting of Human Immunodeficiency Virus
Emily A. Klein, Michael Guiou, D. Gregory Farwell, Quang Luu, Derick H Lau, Kerri Stuart, Andrew T M Vaughan, Srinivasan Vijayakumar, Allen M. Chen> ;International Journal of Radiation Oncology, Biology, Physics. 2011 Jan 1
117 citations
Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.
Allen M. Chen, B. Li, Derick H Lau, D. Gregory Farwell, Quang Luu, Kerri Stuart, Kathleen Newman, James A. Purdy, Srinivasan Vijayakumar> ;International Journal of Radiation Oncology, Biology, Physics. 2010 Nov 15
48 citations
Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
Allen M. Chen, D. Gregory Farwell, Derick H Lau, B. Li, Quang Luu, Paul J. Donald> ;International Journal of Radiation Oncology, Biology, Physics. 2011 Oct 1
11 citations
Escalating weekly doses of cetuximab and correlation with skin toxicity: A phase I study
Cheryl Ho, Randeep Sangha, Laurel A. Beckett, Michael Tanaka, Derick H Lau, Daniel B. Eisen, Rachel A. Burich, Paul A. Luciw, Imran Khan, Philip C. Mack, David R. Gand...> ;Investigational New Drugs. 2011 Aug 1
34 citations
Late esophageal toxicity after radiation therapy for head and neck cancer
Allen M. Chen, B. Li, Richard L. Jennelle, Derick H Lau, Claus Chunli Yang, Jean Courquin, Srinivasan Vijayakumar, James A. Purdy> ;Head & Neck. 2009 Jun 17
76 citations
Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modul...
B. Li, Dan Li, Derick H Lau, D. Gregory Farwell, Quang Luu, David M. Rocke, Kathleen Newman, Jean Courquin, James A. Purdy, Allen M. Chen> ;Radiation Oncology. 2009 Nov 12
8 citations
LAS0811: from combinatorial chemistry to activation of antioxidant response element.
Ming Zhu, Hyounggee Baek, Ruiwu Liu, Aimin Song, Kit S. Lam, Derick H Lau> ;Journal of Biomedicine & Biotechnology. 2009 Sep 24
40 citations
Intermittent Erlotinib in Combination with Pemetrexed: Phase I Schedules Designed to Achieve Pharmacodynamic Separation
Angela M. Davies, Cheryl Ho, Laurel A. Beckett, Derick H Lau, Sidney A. Scudder, Primo N. Lara, Natasha Perkins, David R. Gandara> ;Journal of Thoracic Oncology. 2009 Jul 1
Join now to see all

DerickHon ManLauMD

Dr. Lau is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Viewing the full profile is available to verified healthcare professionals only.